TLDR Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.
A survey conducted among dermatologists in the UK and Ireland reveals the growing use of low-dose oral minoxidil (LDOM) as an off-label treatment for various hair loss conditions. The survey, which included 29 respondents, found that LDOM is frequently prescribed for androgenic alopecia, frontal fibrosing alopecia/lichen planopilaris, alopecia areata, and telogen effluvium. Dermatologists often use LDOM as monotherapy for male and female pattern hair loss, but as an adjunct therapy for other conditions, often combined with medications like oral antiandrogens, spironolactone, hydroxychloroquine, tetracyclines, and Janus kinase inhibitors. Monitoring practices vary, with some dermatologists performing baseline blood tests and blood pressure checks. The study highlights the diverse prescribing practices and the widespread acceptance of LDOM in treating hair loss.
April 2025 in “Acta Dermato Venereologica” Accurate diagnosis is crucial to distinguish between allergy and irritation from topical minoxidil.
March 2025 in “Journal of the American Academy of Dermatology” Systemic minoxidil improves hair density in women with female pattern hair loss over time.
February 2024 in “Cosmoderma” Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.
February 2020 in “The Pharmaceutical Society of Japan” 8 citations
,
October 2015 in “PubMed” 5% minoxidil foam effectively treats female hair loss.
January 2007 in “Strait Pharmaceutical Journal” Water-soluble minoxidil effectively promoted hair growth in mice.
1 citations
,
September 2002 in “PubMed” Minoxidil helps stimulate hair growth and reduce hair loss in women with androgenic alopecia.
370 citations
,
September 1999 in “The New England Journal of Medicine” Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.
127 citations
,
July 1996 in “Journal of The American Academy of Dermatology” Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.
36 citations
,
January 1991 in “PubMed” 2% Minoxidil does not prevent hair loss during chemotherapy.